TP53 and cancer: By gain of prosurvival signals (e.g., NF-κB and BCL2) and/or by loss of surveillance mechanism (e.g., MDM2 and P53), cancer cells can tolerate the enhanced MYC level and thereby avoid programmed cell death (Wagner and Nebreda, 2009 ▶).